Table 1.

Effect of MZF on the expression of DC maturation markers

Maturation marker	MZF concentration (μg/ml)				LPS
	0	100	200	400
CD80
Percentage of positive cells	31.96 ± 0.58	34.91 ± 0.62*	36.34 ± 0.36*	44.35 ± 0.38*	66.33 ± 0.39*
MFI	74.68 ± 2.08	70.28 ± 2.20	75.04 ± 1.91	102.88 ± 2.97*	165.98 ± 4.43*
CD86
Percentage of positive cells	35.20 ± 2.94	42.49 ± 0.35	47.16 ± 1.14*	61.29 ± 8.47*	72.97 ± 0.78*
MFI	55.56 ± 6.81	88.70 ± 4.04*	92.01 ± 2.03*	109.76 ± 2.26*	186.50 ± 2.25*
CD83
Percentage of positive cells	10.13 ± 0.38	13.06 ± 1.13	17.94 ± 0.43*	24.69 ± 0.59*	24.83 ± 0.49*
MFI	4.98 ± 0.08	5.99 ± 0.25*	6.43 ± 0.20*	8.72 ± 0.54*	9.50 ± 0.59*
MHC class II
Percentage of positive cells	28.25 ± 0.43	29.06 ± 0.71	32.69 ± 0.69*	43.95 ± 0.24*	40.17 ± 0.22*
MFI	131.59 ± 2.85	143.05 ± 2.90*	144.75 ± 3.17*	179.11 ± 1.97*	182.85 ± 3.97*

DCs (1 × 10⁶ cells/ml) were stimulated with MZF (0–400 μg/ml) or LPS (100 ng/ml) for 24 h. The values are percentages of DCs (CD11c⁺ cells) expressing indicated markers and the mean fluorescence intensity (MFI). Values are expressed as mean ± SE (n = 3)

* p < 0.05 versus control